Up | AC
Home Page
Food and
Drug Administration
Cardiovascular and Renal Drugs Advisory Committee
June 24, 2008
BRIEFING INFORMATION
FDA
Disclaimer
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).
FDA Briefing Material (pdf)
FDA Attachments (pdf)
Errata (pdf)
Sponsors
Disclaimer
The statements contained in this document(s) are those of the products’ sponsors, not FDA, and FDA does not necessarily agree with the sponsors’ statements. FDA has not made a final determination about the safety or effectiveness of the products described in these documents.
Lantheus Medical Imaging Briefing Material (pdf)
GE Health Care Briefing Material (pdf)
Bracco Imaging Briefing Material (pdf)
